A study on urine micro albuminuria as an isolated risk factor for cardiac morbitdity and mortality in non-diabetics and non-hypertensives
Keywords:
micro albuminuria, cardiovascular, cardiac morbidity, mortality, non-diabetic, non-hypertensiveAbstract
Background: There is a relative paucity of data on the link between urine micro albumin and IHD in non-diabetics as well as non-hypertensive’s compared to diabetics. This study was meant to look for the association between urine micro albumin and in cardiac morbidity and mortality among non-diabetic and non-hypertensive’s, which may further provide insight to the early diagnosis of micro albuminuria and its potential for predicting cardiac morbidity and thus needed inputs for better clinical management. Aims and objectives: To assess the relationship between micro albuminuria and proven risk factors and markers of cardiovascular disease in non-diabetic & non-hyper extensive ischaemic heart disease patients. Materials and methods: Among the 200 patients which were taken in the study, 141 (69.8%) were males and the rest29.2%were females. 34.5% each were from the age of 41-50 years and51-60 years respectively. Only 26 (13.0%) patients were from the age group of morethan60years. Results: The mean age of patients was 50.66 with a SDof 9.33. Majority of males were from the age group of 41-50 years (38.3%), while 42.4% of females were from the age group of 51-60 years. Mean age of male patients was found to be 49.41±9.16,while female patients was of 52.44±9.57.
Downloads
References
Al-Saffar HB, Nassir H, Mitchell A, Philipp S. Micro albuminuria in non-diabetic patients with unstable angina/nonST-segment elevation myocardial infarction. BMC research notes.2015 Dec;8(1):1-7.
Alwan A, Armstrong T, Cowan M, etal. Non communicable diseases country profiles 2011[Internet] 2011. [Lastaccessedin2015]. Availablefrom:http://whqlibdoc.who.int/publications/2011/9789241502283_eng.pdf.
Alwan A, Maclean DR, Riley LM, et al. Monitoring and surveillance of chronic non-communicable diseases: Progress and capacity in high-burden countries. Lancet.2010;376:1861–8.
ArnlövJ, EvansJC, MeigsJB, WangTJ, FoxCS, LevyD, etal. Low-grade albuminuria and incidence of cardiovascular disease events in non hypertensive and non diabetic individuals: The Framingham Heart Study. Circulation 2005;112:969-75
Basu A, Jhala JS. Association of micro albuminuria in non-diabetic and non-hypertensive patients with myocardial infarction. International Journal of Advances in Medicine.2015Jul;2(3):196.
Berton G. Micro albuminuria during acute myocardial infarction; a strong predictor for 1-year mortality. European Heart Journal. 2001;22:1466-1475
Corona AJ, Martinez DR, Avila MH, Haffner S, Williams KE, Villalpando ME, SimonJ, SternM,Gonzalez-VillalpandoC.Micro albuminuria as a predictor of myocardial infarction in a Mexican population: the Mexico City Diabetes Study. Kidney International. 2005Aug1;68:S34-9.
GamitD, VananiB, PatelC, MishraA, PatelA. Evaluation of micro albuminuria in non-diabetic and non-hypertensive patients with acute myocardial infarction.Alcohol.;7:5-8
Gaziano TA, Bitton A, Anand S, et al. Growing epidemic of coronary heart disease in low-and middle-income countries. Curr Probl Cardiol.2010;35:72–115.
Hao G, Wang Z, Zhang L, et al. Prevalence of micro albuminuria among middle-aged population of China: A multiple center cardiovascular repidemological study. Angiology.2015;66(1):49–56.
Haque MJ, Islam MN, Al Aziz MZ, Ashrafuzzaman SM, Banik GC, Rahman AS, Biswas S, Ahasan HN. Association of Cardiovascular Disease with Micro albuminuriain Type 2 Diabetes Mellitus-Study in A Tertiary Care Hospital. Journal of Medicine.2020 Nov9;21(2):76-81.
Hartland A Gosling P. Micro albuminuria: Yet Another Cardiovascular Risk Factor?.Annals of Clinical Biochemistry: An international journal of biochemistry and laboratory medicine.1999;36:700-703
HillegeHL, JanssenWM, BakAA,etal. Prevend study group. Microalbumi-nuria is common, also in a non diabetic, non hypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med.2001;249:519–26.
Jensen JS, Borch JK, Jensen G, Feldt RB (1995) Atherosc-lerotic risk factors are increased in clinically healthy subjects with micro albuminuria. Artherosclerosis112:245-252
Jha PK, Ete T, Malviya A, Das CK, SahaSK, NathD, Kapoor M, Mishra A Micro albuminuria: correlation with prevalence and severity of coronary artery disease in non-diabetics. Journal of clinical medicine research.2017Oct;9(10):838.
Kangwagye P, Rwebembera J, Wilson T, Bajunirwe F. Micro albuminuria and Retinopathy among Hypertensive Non diabetic Patients at a Large Public Outpatient Clinic in South western Uganda. International journal ofnephrology.2018Jun6;2018
Khairallah MK, Ibrahim WH. Frequency and possible associations of albuminuria in patients with essential hypertension: a single-centerexperience. Journal of Current Medical Research and Practice. 2019 Sep1;4(3):373.
Kim YS, Kim HS, Oh HY, Lee MK, Kim CH, Kim YS, Wu D, Johnson-Levonas AO, Oh BH. Prevalence of micro albuminuria and associated risk factors among adult Korean hypertensive patients in a primary care setting. Hypertension Research.2013Sep;36(9):807-23.
Levitt JI. The prognostic significance of protein uria in young collegestudents.AnnInternMed1967;66:685–96.
Memon AG, Kolachi M. Relationship of Micro albumin urea in Non-Diabetic and Non-Hypertensive Patients with A cute Myocardial Infarction.JClinExpCardiolog.2015;6(403):2.
Mogensen CE, Chachati A, Christensen A, Christensen CK, et al. Micro-albuminuria: a nearly marker of renal involve mentin diabetes.UremInvestig.1985;9:85–95.
Mustafa A. Study of Micro albuminuria in Non-Diabetic and Non- Hypertensive Patients with Acute Myocardial Infarction International Journal of Contemporary Medical Research 2020;7(3):C1-C3.
NahaS, NahaK, Pandit VR, Balasubramanian R. Association of micro albuminuria with ischemic heart disease in non-diabetic Asian- Indians:A case control study. Avicenna journal of medicine.2015Jan;5(1):6.
Naira, A., Majeed, B., Begum, H., Rukshana, N., Rahamathullah, N., Khan, Z. A., & Gobi, A. K. (2022). Prevalence of Extended-Spectrum of Beta-Lactamase-producing class a genes in Escherichia coli and Klebsiella pneumoniae isolated from patients urine samples in United Arab Emirates. International Journal of Health Sciences, 6(S5), 4577–4587. https://doi.org/10.53730/ijhs.v6nS5.10081
Parving HH, Jensen HA, Mogensen HA, Evrin PE. Increased urinary albumin excretion rate in benign essential hypertension. Lancet 1974; i:1190–93.
Ratnawati, I. G. A. A., Suandayani, N. K. T., & Sutapa, G. N. (2019). The linearity of x-ray devices radiation output and its relationship with patient thickness. International Journal of Physical Sciences and Engineering, 3(3), 1–6. https://doi.org/10.29332/ijpse.v3n3.351
SandheepJ. Relationship of Micro albuminuria with Ischaemic Heart Disease in Non Diabetics (Doctor aldissertation, Thanjavur Medical College, Thanjavur).
Smith SC, Jr. Reducing the global burden of ischemic heart disease and stroke: A challenge for the cardiovascular community and the United Nations.Circulation.2011;124:278-9.
Sukhija R, Aronow WS, Kakar P, Garza L, Sachdeva R, et al. Relation of micro albuminuria and coronary artery disease in patients with and without diabetes mellitus.AmJCardiol2006;98:279-281.
Suryasa, I. W., Rodríguez-Gámez, M., & Koldoris, T. (2021). Health and treatment of diabetes mellitus. International Journal of Health Sciences, 5(1), i-v. https://doi.org/10.53730/ijhs.v5n1.2864
Taskiran M, Iversen A, Klausen K, Jensen GB, Jensen JS. The association of micro albuminuria with mortality in patients with acute myocardial infarction. A ten-year follow-up study. Heart international.2010 Jun23;5(1).
Wang Y, Yuan A, Chen Y. Correlation between micro albuminuria and cardio vascular events. Int JClinExp Med.2013;6(10):973–8
World Health Organization (WHO). Cardiovascular diseases, fact sheet number 317 [Internet].Geneva, Switzerland: WHO;2013, Available from:http://www.who.int/mediacentre/factsheets/fs317/en/[Lastaccessed in2015].
Published
How to Cite
Issue
Section
Copyright (c) 2022 International journal of health sciences
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Articles published in the International Journal of Health Sciences (IJHS) are available under Creative Commons Attribution Non-Commercial No Derivatives Licence (CC BY-NC-ND 4.0). Authors retain copyright in their work and grant IJHS right of first publication under CC BY-NC-ND 4.0. Users have the right to read, download, copy, distribute, print, search, or link to the full texts of articles in this journal, and to use them for any other lawful purpose.
Articles published in IJHS can be copied, communicated and shared in their published form for non-commercial purposes provided full attribution is given to the author and the journal. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
This copyright notice applies to articles published in IJHS volumes 4 onwards. Please read about the copyright notices for previous volumes under Journal History.
